Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways

Jianxiang Xu(Blood Center of Zhejiang Province), Zhijun Pan(Second Affiliated Hospital of Zhejiang University)
Stem Cell Research & Therapy
May 4, 2021
Cited by 25


Related Papers